
Medicine and Health
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
P. R. Kac, F. González-ortiz, et al.
This groundbreaking study by renowned researchers, including Przemysław R. Kac and Fernando González-Ortiz, explores the promising role of plasma phosphorylated tau (p-tau) at threonine-212 as a potential biomarker for Alzheimer's disease. With an innovative blood-based immunoassay, the research demonstrates high diagnostic accuracy for AD and highlights p-tau212's superiority compared to other biomarkers.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.